 | Up a level |
Fernbach, Sonja; Mair, Nina K; Abela, Irene A; Groen, Kevin; Kuratli, Roger; Lork, Marie; Thorball, Christian W; Bernasconi, Enos; Filippidis, Paraskevas; Leuzinger, Karoline; Notter, Julia; Rauch, Andri; Hirsch, Hans H; Huber, Michael; Günthard, Huldrych F; Fellay, Jacques; Kouyos, Roger D; Hale, Benjamin G (2024). Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies. Journal of experimental medicine, 221(9) Rockefeller University Press 10.1084/jem.20240365
Busnadiego, Idoia; Abela, Irene A; Frey, Pascal M; Hofmaenner, Daniel A; Scheier, Thomas C; Schuepbach, Reto A; Buehler, Philipp K; Brugger, Silvio D; Hale, Benjamin G (2022). Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease. PLoS biology, 20(7), e3001709. Public Library of Science 10.1371/journal.pbio.3001709
Karakus, Umut; Thamamongood, Thiprampai; Ciminski, Kevin; Ran, Wei; Günther, Sira C; Pohl, Marie O; Eletto, Davide; Jeney, Csaba; Hoffmann, Donata; Reiche, Sven; Schinköthe, Jan; Ulrich, Reiner; Wiener, Julius; Hayes, Michael G B; Chang, Max W; Hunziker, Annika; Yángüez, Emilio; Aydillo, Teresa; Krammer, Florian; Oderbolz, Josua; ... (2019). MHC class II proteins mediate cross-species entry of bat influenza viruses. Nature, 567(7746), pp. 109-112. Springer Nature 10.1038/s41586-019-0955-3
